Advertisement

Supply Chain



Plano, Texas-based Argon Medical Devices has acquired Franklin, Ind.-based Promex Technologies, which does business as US Biopsy.

The U.S. Food and Drug Administration has allowed marketing of a new laboratory test that helps determine if certain patients are at risk of developing moderate to severe acute kidney injury within 12 hours of administering the test.

Advertisement

Most Read

Advertisement
Advertisement